Researchers identify potential new strategy to prevent side effects from immunotherapy

Study sheds a light on the cause of an emerging group of endocrine autoimmune diseases that occur in about 20% of patients treated with checkpoint immunotherapy
UCLA cancer reseachers Drs. Melissa Lechner and Maureen Su
Drs. Melissa Lechner (left) and Maureen Su